TE_176

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family MER39
TE superfamily ERV1
TE class LTR
Gene -
Class Intergenic
Coding Non-coding
Tumor-specific score 2.62
Counts of samples TCGA_tumor:134; TCGA_normal:10; GTEx:47
TSS chr1(-):18298317



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_176.11 - Intergenic Non-coding Non-coding chr1(-):18289510,18289530,18290504,18290630,18291055,18291126,18291739,18291799,18295687,18295762,18298240,18298318
teRNA_176.12 - Intergenic Non-coding Non-coding chr1(-):18291550,18291570,18291739,18291799,18295687,18295762,18298240,18298318
teRNA_176.13 - Intergenic Non-coding Non-coding chr1(-):18290610,18290630,18291055,18291126,18291739,18291799,18295687,18295762,18298240,18298318
teRNA_176.14 - Intergenic Non-coding Non-coding chr1(-):18289510,18289530,18291055,18291799,18298240,18298318


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).